• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconFeatured

Featured

Page 67 of 67
Sam Altman’s ouster brings EU regulatory debates into the limelight: ‘We cannot rely on voluntary agreements brokered by visionary leaders’
Tech
Sam Altman’s ouster brings EU regulatory debates into the limelight: ‘We cannot rely on voluntary agreements brokered by visionary leaders’
By ReutersNovember 21, 2023
Britain’s next government will need to raise taxes to tackle an aging population and a surge in borrowing costs
Retail
Britain’s next government will need to raise taxes to tackle an aging population and a surge in borrowing costs
By ReutersNovember 20, 2023
How a Danish wind company caught the ire of Donald Trump and took a $4 billion write-off in its ‘biggest pain point’—the U.S.
Environment
How a Danish wind company caught the ire of Donald Trump and took a $4 billion write-off in its ‘biggest pain point’—the U.S.
By Ryan HoggNovember 17, 2023
Avon survived on door-to-door sales for 137 years. Now, it’s opening its first U.K. stores because its customers have given up being at home
Retail
Avon survived on door-to-door sales for 137 years. Now, it’s opening its first U.K. stores because its customers have given up being at home
By Ryan HoggNovember 14, 2023
Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
Retail
Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
By Ryan HoggNovember 9, 2023
Employees using 3d-printed cement on a housing development in Kenya.
Environment
The construction industry has been a major climate-change offender. This Swiss company’s cement and concrete could help builders get greener
By Peter VanhamNovember 8, 2023
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
Health
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
By Ryan HoggNovember 6, 2023
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
Health
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
By Ryan HoggNovember 2, 2023
More millionaires are expected to leave China this year than any other country, as the end of COVID-zero allows them to finally relocate
Finance
More millionaires are expected to leave China this year than any other country, as the end of COVID-zero allows them to finally relocate
By Nicholas GordonJune 14, 2023
1...
  • 63
  • 64
  • 65
  • 66
  • 67
67
Most Popular
AI
Shark Tank's Kevin O'Leary says if he were 25 today, he'd chase these two booming opportunities in the world of AIplaceholder alt text
By Marco Quiroz-GutierrezJuly 5, 2026
Success
Ex-PepsiCo CEO Indra Nooyi worked from midnight until 5 a.m. as a receptionist to pay for her Yale degree—and she says ‘respect went up’ because of itplaceholder alt text
By Preston ForeJuly 6, 2026
Success
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of livingplaceholder alt text
By Preston ForeJuly 4, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.